$ALMS
ALUMIS INC.

2024 Q4 Form 10-K Financial Statement

#000184736725000012 Filed on March 19, 2025

View on sec.gov

Income Statement

Concept 2024 Q4 2024 2023 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $20.50M
YoY Change
% of Gross Profit
Research & Development $265.6M $137.7M
YoY Change 92.88%
% of Gross Profit
Depreciation & Amortization $3.152M $1.284M
YoY Change 145.48%
% of Gross Profit
Operating Expenses $300.8M $158.2M
YoY Change 90.14%
Operating Profit -$300.8M
YoY Change 90.14%
Interest Expense $3.249M
YoY Change
% of Operating Profit
Other Income/Expense, Net $6.521M -$68.00K
YoY Change -9689.71%
Pretax Income -$155.0M
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$294.2M -$155.0M
YoY Change 89.84%
Net Earnings / Revenue
Basic Earnings Per Share -$10.38
Diluted Earnings Per Share -$10.38 -$2.99
COMMON SHARES
Basic Shares Outstanding 28.34M
Diluted Shares Outstanding 28.34M

Balance Sheet

Concept 2024 Q4 2024 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $169.5M $46.00M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $306.2M $53.36M
YoY Change 473.85%
LONG-TERM ASSETS
Property, Plant & Equipment $20.97M $22.44M
YoY Change -6.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.000K $7.000K
YoY Change 0.0%
Total Long-Term Assets $34.80M $36.26M
YoY Change -4.0%
TOTAL ASSETS
Total Short-Term Assets $306.2M $53.36M
Total Long-Term Assets $34.80M $36.26M
Total Assets $341.0M $89.61M
YoY Change 280.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.624M $1.118M
YoY Change 760.82%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $50.91M $20.87M
YoY Change 143.93%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $50.91M $20.87M
Total Long-Term Liabilities
Total Liabilities $80.89M $53.50M
YoY Change 51.19%
SHAREHOLDERS EQUITY
Retained Earnings -$658.6M -$364.3M
YoY Change 80.78%
Common Stock $1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $260.1M -$339.3M
YoY Change
Total Liabilities & Shareholders Equity $341.0M $89.61M
YoY Change 280.52%

Cashflow Statement

Concept 2024 Q4 2024 2023 Q4
OPERATING ACTIVITIES
Net Income -$294.2M -$155.0M
YoY Change 89.84%
Depreciation, Depletion And Amortization $3.152M $1.284M
YoY Change 145.48%
Cash From Operating Activities -$255.1M -$130.0M
YoY Change 96.27%
INVESTING ACTIVITIES
Capital Expenditures $1.732M $4.499M
YoY Change -61.5%
Acquisitions
YoY Change
Other Investing Activities $64.97M
YoY Change
Cash From Investing Activities -$113.8M $60.47M
YoY Change -288.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.000K
YoY Change -99.99%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 492.4M 89.68M
YoY Change 449.01%
NET CHANGE
Cash From Operating Activities -255.1M -130.0M
Cash From Investing Activities -113.8M 60.47M
Cash From Financing Activities 492.4M 89.68M
Net Change In Cash 123.5M 20.18M
YoY Change 511.91%
FREE CASH FLOW
Cash From Operating Activities -$255.1M -$130.0M
Capital Expenditures $1.732M $4.499M
Free Cash Flow -$256.8M -$134.5M
YoY Change 90.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2024#DerivativeGainLossOnDerivativeNet
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001847367
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2023 alms Fair Value Assets Level1 To Level2 Transfers During Period Amount
FairValueAssetsLevel1ToLevel2TransfersDuringPeriodAmount
0
CY2024 alms Fair Value Assets Level1 To Level2 Transfers During Period Amount
FairValueAssetsLevel1ToLevel2TransfersDuringPeriodAmount
0
CY2023 alms Fair Value Assets Level2 To Level1 Transfers During Period Amount
FairValueAssetsLevel2ToLevel1TransfersDuringPeriodAmount
0
CY2024 alms Fair Value Assets Level2 To Level1 Transfers During Period Amount
FairValueAssetsLevel2ToLevel1TransfersDuringPeriodAmount
0
CY2023 alms Fair Value Liabilities Level1 To Level2 Transfers During Period Amount
FairValueLiabilitiesLevel1ToLevel2TransfersDuringPeriodAmount
0
CY2024 alms Fair Value Liabilities Level1 To Level2 Transfers During Period Amount
FairValueLiabilitiesLevel1ToLevel2TransfersDuringPeriodAmount
0
CY2023 alms Fair Value Liabilities Level2 To Level1 Transfers During Period Amount
FairValueLiabilitiesLevel2ToLevel1TransfersDuringPeriodAmount
0
CY2024 alms Fair Value Liabilities Level2 To Level1 Transfers During Period Amount
FairValueLiabilitiesLevel2ToLevel1TransfersDuringPeriodAmount
0
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2024 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
85960088
CY2024Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2024Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2139
CY2024Q3 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
0.2139
CY2023 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2024#DerivativeGainLossOnDerivativeNet
CY2024Q3 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
0.2139
alms Number Of Days Prior Notice To Increase Or Decrease Interest Threshold Limit
NumberOfDaysPriorNoticeToIncreaseOrDecreaseInterestThresholdLimit
P61D
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-12-31
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
001-42143
CY2024 dei Entity Registrant Name
EntityRegistrantName
Alumis Inc.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1771129
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
280 East Grand Avenue
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
CY2024 dei City Area Code
CityAreaCode
650
CY2024 dei Local Phone Number
LocalPhoneNumber
231-6625
CY2024 dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value per Share
CY2024 dei Trading Symbol
TradingSymbol
ALMS
CY2024 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Public Float
EntityPublicFloat
165400000
CY2024 cyd Cybersecurity Risk Management Processes Integrated Flag
CybersecurityRiskManagementProcessesIntegratedFlag
true
CY2024 cyd Cybersecurity Risk Management Third Party Engaged Flag
CybersecurityRiskManagementThirdPartyEngagedFlag
true
CY2024 cyd Cybersecurity Risk Third Party Oversight And Identification Processes Flag
CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
true
CY2024 cyd Cybersecurity Risk Materially Affected Or Reasonably Likely To Materially Affect Registrant Flag
CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
false
CY2024 cyd Cybersecurity Risk Management Positions Or Committees Responsible Flag
CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
true
CY2024 cyd Cybersecurity Risk Management Positions Or Committees Responsible Report To Board Flag
CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
true
CY2024 dei Auditor Firm
AuditorFirmId
238
CY2024 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2024 dei Auditor Location
AuditorLocation
San Jose, California
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169526000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45996000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
113000
CY2024Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
118737000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
2956000
CY2024Q4 alms Research And Development Prepaid Expenses
ResearchAndDevelopmentPrepaidExpenses
13424000
CY2023Q4 alms Research And Development Prepaid Expenses
ResearchAndDevelopmentPrepaidExpenses
2661000
CY2024Q4 alms Other Prepaid Expense And Assets Current
OtherPrepaidExpenseAndAssetsCurrent
4501000
CY2023Q4 alms Other Prepaid Expense And Assets Current
OtherPrepaidExpenseAndAssetsCurrent
1631000
CY2024Q4 us-gaap Assets Current
AssetsCurrent
306188000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
53357000
CY2024Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1106000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1024000
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20968000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22441000
CY2024Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12723000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12783000
CY2024Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000
CY2024Q4 us-gaap Assets
Assets
340992000
CY2023Q4 us-gaap Assets
Assets
89612000
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9624000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1118000
CY2024Q4 alms Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
29149000
CY2023Q4 alms Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
10946000
CY2024Q4 alms Other Accrued Expenses And Liabilities Current
OtherAccruedExpensesAndLiabilitiesCurrent
10580000
CY2023Q4 alms Other Accrued Expenses And Liabilities Current
OtherAccruedExpensesAndLiabilitiesCurrent
7087000
CY2024Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1557000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1720000
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50910000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20871000
CY2024Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29165000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30860000
CY2024Q4 alms Share Repurchase Liability
ShareRepurchaseLiability
813000
CY2023Q4 alms Share Repurchase Liability
ShareRepurchaseLiability
1771000
CY2024Q4 us-gaap Liabilities
Liabilities
80888000
CY2023Q4 us-gaap Liabilities
Liabilities
53502000
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2024Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2024Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
89016578
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
85960088
CY2024Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0
CY2023Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
370540000
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
375370000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
918610000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25055000
CY2024Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
40000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2000
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-658551000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-364318000
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
260104000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-339260000
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
340992000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89612000
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
265554000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
137676000
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35200000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20498000
CY2024 us-gaap Operating Expenses
OperatingExpenses
300754000
CY2023 us-gaap Operating Expenses
OperatingExpenses
158174000
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-300754000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-158174000
CY2024 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
12020000
CY2023 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
3368000
CY2024 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5406000
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-119000
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-93000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-68000
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6521000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3181000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-294233000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-154993000
CY2024 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
38000
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
129000
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-294195000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-154864000
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-10.38
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-10.38
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-72.08
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-72.08
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28341866
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28341866
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2150186
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2150186
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
67960088
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
285473000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-195242000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
277000
CY2023 alms Stock Issued During Period Value Early Exercise Of Stock Options
StockIssuedDuringPeriodValueEarlyExerciseOfStockOptions
1921000
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
23000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8625000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
129000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-154993000
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
85960088
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
375370000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-339260000
CY2024 alms Conversion And Redesignation Of Temporary Equity Shares
ConversionAndRedesignationOfTemporaryEquityShares
-168489871
CY2024 alms Conversion And Redesignation Of Temporary Equity Amount
ConversionAndRedesignationOfTemporaryEquityAmount
-639237000
CY2024 alms Conversion And Redesignation Of Temporary Equity Into Permanent Equity Amount
ConversionAndRedesignationOfTemporaryEquityIntoPermanentEquityAmount
639237000
CY2024 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
375000
CY2024 alms Stock Issued During Period Value Early Exercise Of Stock Options
StockIssuedDuringPeriodValueEarlyExerciseOfStockOptions
1154000
CY2024 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
20000
CY2024 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19457000
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
38000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-294233000
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
260104000
CY2024 us-gaap Profit Loss
ProfitLoss
-294233000
CY2023 us-gaap Profit Loss
ProfitLoss
-154993000
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
19457000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
8625000
CY2024 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5406000
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-119000
CY2024 alms Accretion Expense Net Of Discounts On Marketable Securities
AccretionExpenseNetOfDiscountsOnMarketableSecurities
-3685000
CY2023 alms Accretion Expense Net Of Discounts On Marketable Securities
AccretionExpenseNetOfDiscountsOnMarketableSecurities
-544000
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3152000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1284000
CY2024 alms Non Cash Lease Expense
NonCashLeaseExpense
60000
CY2023 alms Non Cash Lease Expense
NonCashLeaseExpense
2010000
CY2024 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-266000
CY2023 alms Write Off Of Deferred Offering Costs
WriteOffOfDeferredOfferingCosts
555000
CY2023 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-645000
CY2024 alms Increase Decrease In Research And Development Prepaid Expenses
IncreaseDecreaseInResearchAndDevelopmentPrepaidExpenses
10763000
CY2023 alms Increase Decrease In Research And Development Prepaid Expenses
IncreaseDecreaseInResearchAndDevelopmentPrepaidExpenses
-5526000
CY2024 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2870000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
340000
CY2024 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
8506000
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-642000
CY2024 alms Increase Decrease In Research And Development Accrued Expenses
IncreaseDecreaseInResearchAndDevelopmentAccruedExpenses
18203000
CY2023 alms Increase Decrease In Research And Development Accrued Expenses
IncreaseDecreaseInResearchAndDevelopmentAccruedExpenses
5168000
CY2024 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
3542000
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2490000
CY2024 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1858000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-144000
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-255078000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-129975000
CY2024 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
128000000
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
76250000
CY2024 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
240058000
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
11279000
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1732000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4499000
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-113790000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
60472000
CY2024 alms Proceeds From Issuance Of Redeemable Convertible Preferred Stock And Derivative Liability Net Of Issuance Costs
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockAndDerivativeLiabilityNetOfIssuanceCosts
258461000
CY2023 alms Proceeds From Issuance Of Redeemable Convertible Preferred Stock And Derivative Liability Net Of Issuance Costs
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockAndDerivativeLiabilityNetOfIssuanceCosts
89778000
CY2024 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
193316000
CY2024 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
40000000
CY2024 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
596000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
453000
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
485000
CY2024 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
64000
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
492367000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
89682000
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
123499000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
20179000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47133000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26954000
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170632000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47133000
CY2024 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
168489871
CY2024 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
639237000
CY2024 alms Settlement Of Derivative Liability Upon Issuance Of Redeemable Convertible Preferred Stock
SettlementOfDerivativeLiabilityUponIssuanceOfRedeemableConvertiblePreferredStock
14319000
CY2023 alms Settlement Of Derivative Liability Upon Issuance Of Redeemable Convertible Preferred Stock
SettlementOfDerivativeLiabilityUponIssuanceOfRedeemableConvertiblePreferredStock
2231000
CY2024 alms Recognition Of Derivative Liability Upon Issuance Of Convertible Preferred Stock
RecognitionOfDerivativeLiabilityUponIssuanceOfConvertiblePreferredStock
8913000
CY2023 alms Recognition Of Derivative Liability Upon Issuance Of Convertible Preferred Stock
RecognitionOfDerivativeLiabilityUponIssuanceOfConvertiblePreferredStock
2112000
CY2024 alms Vesting Of Exercised Stock Options And Restricted Shares Of Common Stock
VestingOfExercisedStockOptionsAndRestrictedSharesOfCommonStock
1174000
CY2023 alms Vesting Of Exercised Stock Options And Restricted Shares Of Common Stock
VestingOfExercisedStockOptionsAndRestrictedSharesOfCommonStock
1944000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
14255000
CY2023 alms Property And Equipment Acquired Through Tenant Improvement
PropertyAndEquipmentAcquiredThroughTenantImprovement
16691000
CY2023 alms Purchases Of Property And Equipment In Other Accrued Expenses And Liabilities
PurchasesOfPropertyAndEquipmentInOtherAccruedExpensesAndLiabilities
49000
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169526000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45996000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
113000
CY2024Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1106000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1024000
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170632000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47133000
CY2023Q4 alms Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-294200000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-155000000
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-255100000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-130000000
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-658600000
CY2024Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
288300000
CY2024Q1 alms Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On an ongoing basis, the Company evaluates estimates and assumptions, including but not limited to those related to accruals for research and development expenses and accruals, stock-based compensation expense, the fair value of common stock and the fair value of the derivative liability. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from those estimates.</p>
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments, which potentially subject the Company to concentration of credit risk, consist primarily of cash and cash equivalents, investments in marketable securities and restricted cash. The Company maintains bank deposits in federally insured financial institutions and certain of these deposits exceed federally insured limits. To date, the Company has not experienced any losses on its deposits of cash and periodically evaluates the creditworthiness of the financial institutions at which its bank deposits are maintained.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company may also invest in money market funds, U.S. treasuries, commercial paper, corporate bonds, supranational debt securities and agency bonds, which can be subject to certain credit risks. The Company mitigates the risks by investing in high-grade instruments, limiting its exposure to any one issuer and monitoring the ongoing creditworthiness of the financial institutions and issuers. The Company has not experienced any loss of principal on its financial instruments.</p>
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2024Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2024Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2024 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
8913000
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
2112000
CY2024 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
5406000
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
119000
CY2024 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
14319000
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
2231000
CY2024Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
118697000
CY2024Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
45000
CY2024Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5000
CY2024Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
118737000
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
2954000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2956000
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2023 alms Debt Securities Available For Sale Impairment Loss
DebtSecuritiesAvailableForSaleImpairmentLoss
0
CY2024 alms Debt Securities Available For Sale Impairment Loss
DebtSecuritiesAvailableForSaleImpairmentLoss
0
CY2024Q4 us-gaap Prepaid Insurance
PrepaidInsurance
695000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
111000
CY2024Q4 alms Prepaid Subscriptions Current
PrepaidSubscriptionsCurrent
1232000
CY2023Q4 alms Prepaid Subscriptions Current
PrepaidSubscriptionsCurrent
703000
CY2024Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
698000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
108000
CY2024Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1114000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
614000
CY2024Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
762000
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
95000
CY2024Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4501000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1631000
CY2024Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25525000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23849000
CY2024Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4557000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1408000
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20968000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22441000
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3200000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1300000
CY2024Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7765000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5585000
CY2024Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2657000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1093000
CY2024Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
158000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
409000
CY2024Q4 alms Other Accrued Expenses And Liabilities Current
OtherAccruedExpensesAndLiabilitiesCurrent
10580000
CY2023Q4 alms Other Accrued Expenses And Liabilities Current
OtherAccruedExpensesAndLiabilitiesCurrent
7087000
CY2021Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
14000
CY2023Q3 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-600000
CY2022Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
12000
CY2022Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
55000
CY2023Q4 us-gaap Incentive To Lessee
IncentiveToLessee
17200000
CY2022 alms Proceeds From Tenant Improvement Allowance Received
ProceedsFromTenantImprovementAllowanceReceived
500000
CY2023 alms Proceeds From Tenant Improvement Allowance Received
ProceedsFromTenantImprovementAllowanceReceived
16700000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
37900000
CY2023Q1 alms Lessee Operating Lease Liability Gross Fixed Payment
LesseeOperatingLeaseLiabilityGrossFixedPayment
54600000
CY2023Q1 alms Lessee Operating Lease Incentive Receivable Current
LesseeOperatingLeaseIncentiveReceivableCurrent
16700000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
14100000
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.114
CY2022Q3 alms Lessee Operating Lease Incentive Receivable Current
LesseeOperatingLeaseIncentiveReceivableCurrent
16700000
CY2022Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2024Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
22000
CY2024Q4 us-gaap Lessee Operating Lease Lease Not Yet Commenced Existence Of Option To Extend
LesseeOperatingLeaseLeaseNotYetCommencedExistenceOfOptionToExtend
true
CY2024Q4 us-gaap Lessee Operating Lease Lease Not Yet Commenced Renewal Term1
LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1
P2Y
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1100000
CY2024Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1100000
CY2024 us-gaap Operating Lease Cost
OperatingLeaseCost
3469000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
4747000
CY2024 us-gaap Variable Lease Cost
VariableLeaseCost
1202000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
545000
CY2024 us-gaap Lease Cost
LeaseCost
4671000
CY2023 us-gaap Lease Cost
LeaseCost
5292000
CY2024 us-gaap Operating Lease Payments
OperatingLeasePayments
5299000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
2903000
CY2024Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y6M
CY2024Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.114
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.114
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4959000
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5125000
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5296000
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5474000
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5658000
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
21857000
CY2024Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
48369000
CY2024Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
17647000
CY2024Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
30722000
CY2023Q2 alms Redeemable Convertible Preferred Stock Call Option
RedeemableConvertiblePreferredStockCallOption
2100000
CY2023Q4 alms Derivative Liability Amount Reclassified To Temporary Equity
DerivativeLiabilityAmountReclassifiedToTemporaryEquity
2200000
CY2024Q1 alms Number Of Freestanding Financial Instruments
NumberOfFreestandingFinancialInstruments
2
CY2024Q1 alms Fair Value Of Freestanding Financial Instruments
FairValueOfFreestandingFinancialInstruments
8900000
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
89016578
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
85960088
CY2023Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
370540000
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
375370000
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
17095105
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
23779443
CY2024Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.84
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.23
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4603443
CY2024Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.84
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
700000
CY2024Q1 alms Share Based Payment Arrangement Plan Modification Incremental Cost Associated With Vested Options
ShareBasedPaymentArrangementPlanModificationIncrementalCostAssociatedWithVestedOptions
100000
CY2024Q1 alms Share Based Payment Arrangement Plan Modification Incremental Cost Associated With Unvested Options
ShareBasedPaymentArrangementPlanModificationIncrementalCostAssociatedWithUnvestedOptions
600000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5096086
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.68
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15033000
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2902385
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.68
CY2024 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
72201
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.26
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
333000
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
255362
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.23
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7670908
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.59
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1777000
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6565317
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.31
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y
CY2024Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1777000
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6565317
CY2024Q4 alms Share Based Compensation Arrangement By Share Based Payment Award Options Unvested And Early Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedAndEarlyExercisableNumber
3906969
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.92
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.93
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
5800000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8100000
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19457000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8625000
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19457000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8625000
CY2024Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
54400000
CY2024 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-294233000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-154993000
CY2024 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
28579979
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2649038
CY2024 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
238113
CY2023 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
498852
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28341866
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28341866
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2150186
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2150186
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-10.38
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-10.38
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-72.08
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-72.08
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9608054
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23839676
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-61789000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-32548000
CY2024 alms Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
3000000
CY2023 alms Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
7000
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
64923000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
34961000
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
3356000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
892000
CY2024 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
9520000
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
3322000
CY2024 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
30000
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
10000
CY2024Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21573000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10519000
CY2024Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
17407000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
6243000
CY2024Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
74211000
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
39059000
CY2024Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
115000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
15000
CY2024Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3088000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1361000
CY2024Q4 alms Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
6452000
CY2023Q4 alms Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
6842000
CY2024Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
11832000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4567000
CY2024Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
134678000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
68606000
CY2024Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
127990000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
61404000
CY2024Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
6688000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7202000
CY2024Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
885000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1025000
CY2024Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
5803000
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
6177000
CY2024Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6688000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7202000
CY2024 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
66600000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
35400000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4116000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2451000
CY2024 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1336000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3572000
CY2024 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
2655000
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
1907000
CY2024Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2797000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4116000
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2024 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2024Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2024 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2024Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024 ecd Insider Trd Policies Proc Adopted Flag
InsiderTrdPoliciesProcAdoptedFlag
true

Files In Submission

Name View Source Status
0001847367-25-000012-index-headers.html Edgar Link pending
0001847367-25-000012-index.html Edgar Link pending
0001847367-25-000012.txt Edgar Link pending
0001847367-25-000012-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20241231.xsd Edgar Link pending
tmb-20241231x10k.htm Edgar Link pending
tmb-20241231x10k001.jpg Edgar Link pending
tmb-20241231xex10d9.htm Edgar Link pending
tmb-20241231xex10d9001.jpg Edgar Link pending
tmb-20241231xex19d1.htm Edgar Link pending
tmb-20241231xex23d1.htm Edgar Link pending
tmb-20241231xex31d1.htm Edgar Link pending
tmb-20241231xex31d2.htm Edgar Link pending
tmb-20241231xex32d1.htm Edgar Link pending
tmb-20241231xex32d2.htm Edgar Link pending
tmb-20241231xex4d3.htm Edgar Link pending
tmb-20241231xex97d1.htm Edgar Link pending
tmb-20241231_cal.xml Edgar Link unprocessable
tmb-20241231_def.xml Edgar Link unprocessable
tmb-20241231_lab.xml Edgar Link unprocessable
tmb-20241231_pre.xml Edgar Link unprocessable
tmb-20241231x10k_htm.xml Edgar Link completed